• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 III-E 型 CRISPR-Cas 系统中的靶 RNA 引导蛋白酶活性。

Target RNA-guided protease activity in type III-E CRISPR-Cas system.

机构信息

The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Haihe Laboratory of Cell Ecosystem, Tianjin Institute of Immunology, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.

State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei 430062, China.

出版信息

Nucleic Acids Res. 2022 Dec 9;50(22):12913-12923. doi: 10.1093/nar/gkac1151.

DOI:10.1093/nar/gkac1151
PMID:36484100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9825189/
Abstract

The type III-E CRISPR-Cas systems are newly identified adaptive immune systems in prokaryotes that use a single Cas7-11 protein to specifically cleave target RNA. Cas7-11 could associate with Csx29, a putative caspase-like protein encoded by the gene frequently found in the type III-E loci, suggesting a functional linkage between the RNase and protease activities in type III-E systems. Here, we demonstrated that target RNA recognition would stimulate the proteolytic activity of Csx29, and protein Csx30 is the endogenous substrate. More interestingly, while the cognate target RNA recognition would activate Csx29, non-cognate target RNA with the complementary 3' anti-tag sequence inhibits the enzymatic activity. Csx30 could bind to the sigma factor RpoE, which may initiate the stress response after proteolytic cleavage. Combined with biochemical and structural studies, we have elucidated the mechanisms underlying the target RNA-guided proteolytic activity of Csx29. Our work will guide further developments leveraging this simple RNA targeting system for RNA and protein-related applications.

摘要

III-E 型 CRISPR-Cas 系统是原核生物中新发现的适应性免疫系统,它使用单个 Cas7-11 蛋白特异性切割靶 RNA。Cas7-11 可以与 Csx29 结合,Csx29 是一种假定的半胱氨酸蛋白酶样蛋白,由基因编码,该基因在 III-E 型基因座中经常发现,这表明 III-E 型系统中的核糖核酸酶和蛋白酶活性之间存在功能联系。在这里,我们证明了靶 RNA 的识别会刺激 Csx29 的蛋白水解活性,而蛋白质 Csx30 是内源性底物。更有趣的是,虽然同源靶 RNA 的识别会激活 Csx29,但具有互补 3'反标签序列的非同源靶 RNA 会抑制酶活性。Csx30 可以与 sigma 因子 RpoE 结合,这可能会在蛋白水解切割后引发应激反应。结合生化和结构研究,我们阐明了 Csx29 靶 RNA 指导的蛋白水解活性的机制。我们的工作将指导进一步利用这个简单的 RNA 靶向系统进行 RNA 和蛋白质相关应用的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/5a320db1e263/gkac1151fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/722671dc3d3c/gkac1151fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/327cced134bd/gkac1151fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/956dc2e1060b/gkac1151fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/f7d96f091592/gkac1151fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/5a320db1e263/gkac1151fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/722671dc3d3c/gkac1151fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/327cced134bd/gkac1151fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/956dc2e1060b/gkac1151fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/f7d96f091592/gkac1151fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed06/9825189/5a320db1e263/gkac1151fig5.jpg

相似文献

1
Target RNA-guided protease activity in type III-E CRISPR-Cas system.靶向 III-E 型 CRISPR-Cas 系统中的靶 RNA 引导蛋白酶活性。
Nucleic Acids Res. 2022 Dec 9;50(22):12913-12923. doi: 10.1093/nar/gkac1151.
2
RNA-triggered protein cleavage and cell growth arrest by the type III-E CRISPR nuclease-protease.III-E 型 CRISPR 核酸酶-蛋白酶通过 RNA 触发的蛋白切割和细胞生长抑制。
Science. 2022 Nov 25;378(6622):882-889. doi: 10.1126/science.add7347. Epub 2022 Nov 3.
3
Structure and function of a bacterial type III-E CRISPR-Cas7-11 complex.细菌III-E型CRISPR-Cas7-11复合物的结构与功能
Nat Microbiol. 2022 Dec;7(12):2078-2088. doi: 10.1038/s41564-022-01256-z. Epub 2022 Oct 27.
4
The gRAMP CRISPR-Cas effector is an RNA endonuclease complexed with a caspase-like peptidase.gRAMP CRISPR-Cas效应器是一种与半胱天冬酶样肽酶复合的RNA内切核酸酶。
Science. 2021 Sep 17;373(6561):1349-1353. doi: 10.1126/science.abk2718. Epub 2021 Aug 26.
5
Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector.III-E 型 CRISPR-Cas 效应蛋白的冷冻电镜结构和蛋白酶活性
Nat Microbiol. 2023 Mar;8(3):522-532. doi: 10.1038/s41564-022-01316-4. Epub 2023 Jan 26.
6
Craspase is a CRISPR RNA-guided, RNA-activated protease.Craspase 是一种 CRISPR RNA 导向的、RNA 激活的蛋白酶。
Science. 2022 Sep 16;377(6612):1278-1285. doi: 10.1126/science.add5064. Epub 2022 Aug 25.
7
Target RNA activates the protease activity of Craspase to confer antiviral defense.靶 RNA 激活 Caspase 的蛋白酶活性以赋予抗病毒防御。
Mol Cell. 2022 Dec 1;82(23):4503-4518.e8. doi: 10.1016/j.molcel.2022.10.007. Epub 2022 Oct 27.
8
The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.Csm6 的核糖核酸酶活性是 III-A 型 CRISPR-Cas 系统对抗质粒细胞免疫所必需的。
RNA Biol. 2019 Apr;16(4):449-460. doi: 10.1080/15476286.2018.1493334. Epub 2018 Aug 1.
9
RNA-activated protein cleavage with a CRISPR-associated endopeptidase.RNA 激活的蛋白切割与 CRISPR 相关的内切酶。
Science. 2022 Nov 25;378(6622):874-881. doi: 10.1126/science.add7450. Epub 2022 Nov 3.
10
Molecular mechanism of active Cas7-11 in processing CRISPR RNA and interfering target RNA.Cas7-11 在加工 CRISPR RNA 和干扰靶 RNA 中的活性的分子机制。
Elife. 2022 Oct 3;11:e81678. doi: 10.7554/eLife.81678.

引用本文的文献

1
Structural basis for regulation of a CBASS-CRISPR-Cas defense island by a transmembrane anti-σ factor and its ECF σ partner.跨膜抗σ因子及其 ECF σ 伴侣调控 CBASS-CRISPR-Cas 防御岛的结构基础。
Sci Adv. 2024 Oct 25;10(43):eadp1053. doi: 10.1126/sciadv.adp1053.
2
Structural basis for the activity of the type VII CRISPR-Cas system.VII 型 CRISPR-Cas 系统活性的结构基础。
Nature. 2024 Sep;633(8029):465-472. doi: 10.1038/s41586-024-07815-0. Epub 2024 Aug 14.
3
CRISPR technology in human diseases.用于人类疾病治疗的CRISPR技术。

本文引用的文献

1
RNA-triggered protein cleavage and cell growth arrest by the type III-E CRISPR nuclease-protease.III-E 型 CRISPR 核酸酶-蛋白酶通过 RNA 触发的蛋白切割和细胞生长抑制。
Science. 2022 Nov 25;378(6622):882-889. doi: 10.1126/science.add7347. Epub 2022 Nov 3.
2
RNA-activated protein cleavage with a CRISPR-associated endopeptidase.RNA 激活的蛋白切割与 CRISPR 相关的内切酶。
Science. 2022 Nov 25;378(6622):874-881. doi: 10.1126/science.add7450. Epub 2022 Nov 3.
3
Target RNA activates the protease activity of Craspase to confer antiviral defense.
MedComm (2020). 2024 Jul 29;5(8):e672. doi: 10.1002/mco2.672. eCollection 2024 Aug.
4
Molecular and structural basis of an ATPase-nuclease dual-enzyme anti-phage defense complex.一种ATP酶-核酸酶双酶抗噬菌体防御复合物的分子和结构基础
Cell Res. 2024 Aug;34(8):545-555. doi: 10.1038/s41422-024-00981-w. Epub 2024 Jun 4.
5
Structural basis of negative regulation of CRISPR-Cas7-11 by TPR-CHAT.TPR-CHAT 对 CRISPR-Cas7-11 的负调控的结构基础。
Signal Transduct Target Ther. 2024 May 13;9(1):111. doi: 10.1038/s41392-024-01821-4.
6
Craspase Orthologs Cleave a Nonconserved Site in Target Protein Csx30.Craspase 同源物在靶蛋白 Csx30 中裂解一个非保守位点。
ACS Chem Biol. 2024 May 17;19(5):1051-1055. doi: 10.1021/acschembio.3c00788. Epub 2024 Apr 11.
7
Harnessing CRISPR-Cas adaptation for RNA recording and beyond.利用 CRISPR-Cas 适应性进行 RNA 记录及其他应用
BMB Rep. 2024 Jan;57(1):40-49. doi: 10.5483/BMBRep.2023-0050.
8
An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover.一种古菌病毒编码的抗 CRISPR 蛋白通过抑制 Cas RNP 复合物的周转来抑制 III-B 型免疫。
Nucleic Acids Res. 2023 Nov 27;51(21):11783-11796. doi: 10.1093/nar/gkad804.
9
A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.CRISPR/Cas 综述:一种用于癌症筛查、诊断和临床治疗的多功能工具。
Funct Integr Genomics. 2023 May 26;23(2):182. doi: 10.1007/s10142-023-01117-w.
10
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.发现多样化的 CRISPR-Cas 系统和基因组工程工具包的扩展。
Biochemistry. 2023 Dec 19;62(24):3465-3487. doi: 10.1021/acs.biochem.3c00159. Epub 2023 May 16.
靶 RNA 激活 Caspase 的蛋白酶活性以赋予抗病毒防御。
Mol Cell. 2022 Dec 1;82(23):4503-4518.e8. doi: 10.1016/j.molcel.2022.10.007. Epub 2022 Oct 27.
4
Structure and function of a bacterial type III-E CRISPR-Cas7-11 complex.细菌III-E型CRISPR-Cas7-11复合物的结构与功能
Nat Microbiol. 2022 Dec;7(12):2078-2088. doi: 10.1038/s41564-022-01256-z. Epub 2022 Oct 27.
5
Craspase is a CRISPR RNA-guided, RNA-activated protease.Craspase 是一种 CRISPR RNA 导向的、RNA 激活的蛋白酶。
Science. 2022 Sep 16;377(6612):1278-1285. doi: 10.1126/science.add5064. Epub 2022 Aug 25.
6
Structure and engineering of the type III-E CRISPR-Cas7-11 effector complex.III-E 型 CRISPR-Cas7-11 效应物复合物的结构与工程化。
Cell. 2022 Jun 23;185(13):2324-2337.e16. doi: 10.1016/j.cell.2022.05.003. Epub 2022 May 27.
7
ColabFold: making protein folding accessible to all.ColabFold:让蛋白质折叠变得人人可用。
Nat Methods. 2022 Jun;19(6):679-682. doi: 10.1038/s41592-022-01488-1. Epub 2022 May 30.
8
Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18.AcrIIA17 和 AcrIIA18 对 CRISPR-Cas9 的抑制机制。
Nucleic Acids Res. 2022 Jan 11;50(1):512-521. doi: 10.1093/nar/gkab1197.
9
Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.利用单蛋白CRISPR效应物Cas7-11进行可编程RNA靶向
Nature. 2021 Sep;597(7878):720-725. doi: 10.1038/s41586-021-03886-5. Epub 2021 Sep 6.
10
The gRAMP CRISPR-Cas effector is an RNA endonuclease complexed with a caspase-like peptidase.gRAMP CRISPR-Cas效应器是一种与半胱天冬酶样肽酶复合的RNA内切核酸酶。
Science. 2021 Sep 17;373(6561):1349-1353. doi: 10.1126/science.abk2718. Epub 2021 Aug 26.